These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9810164)

  • 1. [Hemostatic abnormalities in ischemic stroke].
    Misz M; Oláh L; Kappelmayer J; Blaskó G; Udvardy M; Fekete I; Csépány T; Ajzner E; Csiba L
    Orv Hetil; 1998 Oct; 139(42):2503-7. PubMed ID: 9810164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.
    Haapaniemi E; Soinne L; Syrjälä M; Kaste M; Tatlisumak T
    Acta Neurol Scand; 2004 Oct; 110(4):242-7. PubMed ID: 15355488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia.
    Anzej S; Bozic M; Antovic A; Peternel P; Gaspersic N; Rot U; Tratar G; Stegnar M
    Thromb Res; 2007; 120(1):39-46. PubMed ID: 17034835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
    Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
    Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
    Agren A; Wiman B; Schulman S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between platelet activation and fibrinolysis in acute stroke patients.
    Wang J; Li J; Liu Q
    Neurosci Lett; 2005 Aug; 384(3):305-9. PubMed ID: 15916851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
    Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
    Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
    Rooth E; Wallen H; Antovic A; von Arbin M; Kaponides G; Wahlgren N; Blombäck M; Antovic J
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):365-70. PubMed ID: 17473579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.